54.17
前日終値:
$53.16
開ける:
$52.56
24時間の取引高:
1.97M
Relative Volume:
1.44
時価総額:
$8.29B
収益:
$700.35M
当期純損益:
$461.90M
株価収益率:
18.88
EPS:
2.8696
ネットキャッシュフロー:
$-14.19M
1週間 パフォーマンス:
+0.37%
1か月 パフォーマンス:
-3.27%
6か月 パフォーマンス:
+46.72%
1年 パフォーマンス:
+61.75%
Tg Therapeutics Inc Stock (TGTX) Company Profile
名前
Tg Therapeutics Inc
セクター
電話
(212) 554-4484
住所
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Compare TGTX vs VRTX, REGN, MRNA, ARGX, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TGTX
Tg Therapeutics Inc
|
54.17 | 8.29B | 700.35M | 461.90M | -14.19M | 2.8696 |
|
VRTX
Vertex Pharmaceuticals Inc
|
523.93 | 132.80B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
805.02 | 82.88B | 14.92B | 4.42B | 3.79B | 41.04 |
|
MRNA
Moderna Inc
|
200.10 | 79.89B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
ARGX
Argen X Se Adr
|
873.71 | 54.94B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
377.63 | 42.72B | 5.76B | 514.49M | 1.10B | 4.4813 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-06 | 再開されました | H.C. Wainwright | Buy |
| 2025-07-10 | 再開されました | Goldman | Neutral |
| 2024-10-29 | 開始されました | TD Cowen | Buy |
| 2023-08-02 | アップグレード | Goldman | Sell → Neutral |
| 2023-06-26 | 再開されました | Jefferies | Buy |
| 2022-05-20 | 開始されました | BofA Securities | Underperform |
| 2022-02-23 | 繰り返されました | B. Riley Securities | Buy |
| 2021-11-15 | ダウングレード | Goldman | Neutral → Sell |
| 2021-04-20 | 開始されました | Goldman | Neutral |
| 2021-04-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-01 | 開始されました | JP Morgan | Overweight |
| 2020-08-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-05 | 開始されました | Evercore ISI | Outperform |
| 2020-01-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-27 | 再開されました | B. Riley FBR | Buy |
| 2019-02-06 | 再開されました | Jefferies | Buy |
| 2018-09-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | 繰り返されました | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | 再開されました | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | 再開されました | H.C. Wainwright | Buy |
| 2017-04-25 | 開始されました | Jefferies | Buy |
| 2017-03-06 | 繰り返されました | FBR & Co. | Outperform |
| 2016-10-06 | 再開されました | Brean Capital | Buy |
| 2016-05-27 | 開始されました | SunTrust | Buy |
| 2015-12-01 | 開始されました | FBR Capital | Outperform |
| 2015-09-09 | 開始されました | Raymond James | Strong Buy |
| 2015-08-12 | 再開されました | H.C. Wainwright | Buy |
| 2015-06-19 | 繰り返されました | Brean Capital | Buy |
| 2014-12-11 | 繰り返されました | ROTH Capital | Buy |
| 2014-12-10 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Tg Therapeutics Inc (TGTX) 最新ニュース
Here's How IDEXX Laboratories Is Placed Ahead of Q3 Earnings - Zacks Investment Research
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
TG Therapeutics (TGTX) Showcases Long-Term MS Trial Data and Adv - GuruFocus
TG Therapeutics reports seven-year BRIUMVI disability and safety findings - Mugglehead Investment Magazine
TG Therapeutics Highlights New Clinical Data Across Multiple Sclerosis Portfolio at MSToronto2026 - TG Therapeutics
TG Therapeutics Highlights New Clinical Data Across Multiple Sclerosis Portfolio at MSToronto2026 - Business Wire
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
TGTX Stock Rises 60% in 6 Months: Here's What You Should Know - Zacks Investment Research
TGTX Stock Rises 60% in 6 Months: Here's What You Should Know - TradingView
Thermo Fisher to Report Q3 Earnings: What's in the Cards? - Zacks Investment Research
TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Sclerosis - BioSpace
TG Therapeutics (TGTX) Reports Five-Year Study Showing BRIUMVI's - GuruFocus
TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Sclerosis - Business Wire
High Growth Tech Stocks To Watch In US October 2026 - Simply Wall Street
TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Sclerosis - TG Therapeutics
How TG’s MS Data Wave At MSToronto2026 At TG Therapeutics (TGTX) Has Changed Its Investment Story - Yahoo Finance
TG Therapeutics (TGTX) Stock May Be Undervalued Despite Fresh Newsflow - Yahoo Finance
TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026 - BioSpace
TG Therapeutics (TGTX) to Present Phase 1 Azer-cel Data and BRIU - GuruFocus
TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026 - Business Wire
TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026 - TG Therapeutics
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance Singapore
TG Therapeutics (NASDAQ:TGTX) Emerges as an Affordable Growth Play in Biotech - ChartMill
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance Australia
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance Australia
After tax other income/expense of TG Therapeutics, Inc. – HAN:NKB2 - TradingView
TG Therapeutics, Inc. Revenue Breakdown – HAN:NKB2 - TradingView
Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm - Morningstar
TG Therapeutics (NasdaqCM:TGTX) Stock Forecast & Analyst Predictions - Simply Wall Street
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo! Finance Canada
TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
TG Therapeutics (NASDAQ:TGTX) Combines Strong Growth With a Tight Technical Breakout Setup - ChartMill
TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 22.59% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
TG Therapeutics Inc (TGTX) Stock Price Today: $56.87 - Pluang
TG Therapeutics Inc (TGTX) Stock Price, Quote, News & History - benzinga.com
TG Therapeutics Eyes $1B Run Rate as BRIUMVI Gains MS Market Share - Yahoo Finance
TG Therapeutics Eyes $1B Run Rate as BRIUMVI Gains MS Market Share - TradingView
TG Therapeutics (TGTX) Could Be 19% Undervalued After Its Recent Rebound - Yahoo Finance
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
TG Therapeutics (NASDAQ: TGTX) director plans $274,794.08 stock sale - Stock Titan
TG Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference | TGTX Stock News - quiverquant.com
TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times
TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - TG Therapeutics
TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire
TG Therapeutics at Cantor conference: briumvi gains momentum By Investing.com - Investing.com Canada
TG Therapeutics at Cantor conference: briumvi gains momentum By Investing.com - Investing.com India
TG Therapeutics at Cantor conference: briumvi gains momentum By Investing.com - Investing.com UK
Tg Therapeutics Inc (TGTX) 財務データ
収益
当期純利益
現金流量
EPS
Tg Therapeutics Inc (TGTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Charney Laurence N | Director |
Sep 10 '26 |
Proposed Sale |
54.96 |
5,000 |
274,794 |
0 |
| Echelard Yann | Director |
Nov 24 '25 |
Sale |
32.57 |
5,000 |
162,850 |
223,816 |
| Echelard Yann | Director |
Nov 24 '25 |
Proposed Sale |
32.57 |
5,000 |
162,850 |
0 |
大文字化:
|
ボリューム (24 時間):